Improving the diagnosis of acute hepatitis c virus infection with expanded viral load criteria

Clinical Infectious Diseases

Volumn 49, Issue 7, 2009, Pages 1051-1060

  McGovern, Barbara H ^a,b   Birch, Christopher E ^a,e   Bowen, Melinda J ^e,f   Reyor, Laura L ^c,e   Nagami, Ellen H ^a,e   Chung, Raymond T ^c,d   Kim, Arthur Y ^d,e  

^a LEMUEL SHATTUCK HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD UNIVERSITY   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SEROLOGY; VIREMIA; VIRUS LOAD;

ADOLESCENT; ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PRISONERS; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD; YOUNG ADULT;

EID: 70349415455     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605561     Document Type: Article

References (40)

1. Alberti A, Boccato S, Vario A, Benvegnu L. Therapy of acute hepatitis C. Hepatology 2002;36:S195-200.
2. Strader DB, Wright TL, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147-1171
3. Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001;33:321-327
4. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452-1457 (Pubitemid 34936632)
5. Gerlach JT, Diepolder HM, Zachoval R, et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125:80-88 (Pubitemid 36799109)
6. Wiegand J, Buggisch P, Boecher W, et al. Early monotherapy with pegylatcd interferon alpha-2b for acute hepatitis C infection: the HEPNET acute-HCV-II study. Hepatology 2006;43:250-256 (Pubitemid 43303993)
7. Chung RT. Acute hepatitis C virus infection. Clin Infect Dis 2005; 41(Suppl1):S14-7.
8. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229
9. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic stcatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999;94:1018-1022 (Pubitemid 29173621)
10. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004;38(Suppl 2):S44-8.
11. Zimmerman HJ, West M. Serum enzyme levels in the diagnosis of hepatic disease. Am J Gastroenterol 1963; 40:387.
12. Kamal S, Moustafa KN, Chen J, et al. Duration of peginterferon therapy in acute hepatitis C: a randomized trial. Hepatology 2006;43:923-931 (Pubitemid 43724617)
13. National Institutes of Health. Consensus Development Conference Statement. Management of Hepatitis C. Washington, DC: National Institutes of Health, 2002.
14. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002; 186:1558-1564 (Pubitemid 35379631)
15. Santantonio T, Sinisi E, Guastadisegni A, et al. Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 2003; 35:104-113 (Pubitemid 41490321)
16. Hofer H, Watkins-Riedcl T, Janata O, et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003; 37:60-64 (Pubitemid 36042145)
17. Hagan H, Campbell J, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep 2006;121:710-719 (Pubitemid 46280261)
18. Garfein RS, Golub ET, Greenberg AE, et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS 2007;21:1923-1932 (Pubitemid 47329769)
19. Nguyen TT, Sedghi-Vaziri A, Wilkes LB, et al. Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection. J Viral Hepat 1996;3:75-78 (Pubitemid 126734187)
20. Gordon SC, Dailey PJ, Silverman A, Khan BA, Kodali VP, Wilber JC. Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification. Hepatology 1998;28:1702-1706 (Pubitemid 28549144)
21. Fanning L, Kenny-Walsh E, Levis J, et al. Natural fluctuations of hepatitis C viral load in a homogeneous patient population: a prospective study. Hepatology 2000;31:225-229 (Pubitemid 30033711)
22. Kuramoto IK, Moriya T, Schoening V, Holland PV. Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection. J Viral Hepat 2002;9:36-42. (Pubitemid 36002485)
23. Daar ES, Lynn H, Donfield S, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 2001;26:466-472 (Pubitemid 32489026)
24. Cox AL, Netski DM, Mosbruger T, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005;40:959-961 (Pubitemid 40418300)
25. Kaplan DE, Sugimoto K, Newton K, et al. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology 2007; 132:654-666 (Pubitemid 46274664)
26. Mosley JW, Operskalski EA, Tobler LH, et al. The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy. J Viral Hepat 2008;15:120-128
27. Ticehurst JR, Hamzeh FM, Thomas DL. Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. J Clin Microbiol 2007;45:2426-2433
28. Rodriguez-Torres M, Sulkowski M, Chung RT, Hamzeh FM, Jensen DM. Association of pretreatment and on-treatment factors with rapid virologie response in HCV genotype 1-infected patients treated with peginterferon alfa-2a/ribavirin (abstract 1305). In: Program and abstaracts of the American Association for the Study of Liver Diseases (Boston). 2007.
29. Santantonio T, Fasano M, Sinisi E, et al. Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. J Hepatol 2005; 42:329-333 (Pubitemid 40254246)
30. Santantonio T, Medda E, Ferrari C, et al. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis 2006;43:1154-1159 (Pubitemid 44632798)
31. Corey KE, Ross AS, Wurcel A, et al. Outcomes and treatment of acute hepatitis C virus infection in a United States population. Clin Gastroenterol Hepatol 2006;4:1278-1282 (Pubitemid 44512214)
32. + T-cell response in acute hepatitis C. Gastroenterology 1999;117:933-941
33. Ulsenheimer A, Lucas M, Seth NP, et al. Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses. J Viral Hepat 2006; 13:708-714 (Pubitemid 44401200)
34. Villano S, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999;29:908-914 (Pubitemid 29109609)
35. De Rosa F, Bargiacchi O, Audagnotto S, et al. Twelve-week treatment of acute hepatitis C virus with pegylated interferon-alfa 2b in injection drug users. Clin Infect Dis 2007;45:583-588 (Pubitemid 47328638)
36. McGovern B, Wurcel A, Kim AY, et al. Acute hepatitis C virus infection in incarcerated injection drug users. Clin Infect Dis 2006;42:1663-1670 (Pubitemid 43839427)
37. Mieallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006; 13:34-111
38. Wasley A, Miller JT, Finelli L. Surveillance for Acute Viral Hepatitis-United States, 2005. MMWR Surveill Summ 2007;56:1-24.
39. McGovern BH, Nagami EH, Birch CE, Bowen, et al. Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection. J Infect Dis 2009;200:877-881
40. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005;436:946-952 (Pubitemid 41191670)